Description

MaxCyte, Inc. is a global life sciences enterprise dedicated to the identification, advancement, and commercialization of cutting-edge cell therapies. Its product portfolio encompasses a suite of ExPERT electroporation instruments: the ATx, designed for static electroporation in small to medium-scale cell transfection; the STx, a flow electroporation system facilitating protein creation, drug discovery, and the expression of therapeutic targets for cell-based analyses; the GTx, another flow electroporation solution, but tailored for extensive transfection in therapeutic contexts; and the VLx, engineered for exceptionally high-volume cell manipulation. Furthermore, the company supplies disposable processing assemblies (PAs) essential for cell processing and electroporation, alongside complementary accessories such as electroporation buffer solutions and software protocols. Founded in 1998, MaxCyte maintains its headquarters in Rockville, Maryland.